We are a global leader in the design and manufacture of life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.
Operating margin is thin at 7.43%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 3.4%, steady but not accelerating.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$249M
▲ +3.4% YoY
Net Income (TTM)
$7M
▲ +440.0% YoY
Op. Margin
7.43%
▲ +0.7pp YoY
ROIC
5.10%
▲ +2.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$40M
▼ -7.0% YoY
Op. Cash Flow (TTM)
$43M
▼ -8.5% YoY
Net Debt
$58M
Cash & Equiv.
$27M
5Y CAGR: +13.2%
5Y CAGR: +2.4%
Continue Research